2014 Macula Society 37th Annual Meeting

Key Largo, FL US
February 19, 2014 to February 22, 2014

This educational activity is designed to improve patient care and to promote innovative research to push the field forward through reporting of the latest findings from multi-center clinical trials, discussion of investigator initiated studies, and the sharing of the cutting-edge research findings among the Macula Society members and guests.

The Macula Society was founded in 1977 as a society for vitreoretinal physicians, surgeons and researchers to gather, learn, and discuss the new frontiers in retinal surgery, clinical care and treatment and research studies. Annual meetings of the Macula Society provide a forum for reporting on the most innovative research, clinical experience and the latest clinical trial findings in the areas of retinal, macular and vitreous diseases and surgery, and for spirited discussions about new and possibly controversial treatment modalities.

 

ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical College of Wisconsin and The Macula Society. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 18.00 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 


Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 18 hours of participation for continuing education for allied health professionals.
 
 
This meeting was supported by an Unrestricted Education Grant from Alcon, Carl Zeiss, Genentech, Regeneron, Thrombogenics, Heidelberg, Novartis, Optos, Optovue, Notal Vision, Santen, Bauch & Lomb, Ohr, & Topcon.

 

 

Target Audience

  • Vitreoretinal specialists and surgeons-members of the Society
  • Co-authors who are researchers
  • Fellows
  • Ophthalmologists 

Learning Objectives

  • Discuss findings from recently completed multi-center clinical trials in retina
  • Appraise the efficacy and safety results for clinical studies investigating available and emerging treatment options and treatment schedules for macular diseases
  • Implement best practices for these disease states based upon an evaluation of ongoing clinical trials and diagnostic and imaging technologies
Additional information
AttachmentSize
PDF icon 37th Annual Macula Society - Planners and Presenters Financial Disclosures.pdf63.58 KB

Contact

Name: 
Stacy Singerman
Phone Number: 
+1 (216) 839-4949
Email: 
maculasociety@aol.com
Course summary
Available credit: 
  • 18.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 18.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
12/01/2013
Course expires: 
11/17/2014
Event starts: 
02/19/2014 - 3:00pm CST
Event ends: 
02/22/2014 - 1:00pm CST
Cost:
$0.00
Add to calendar: 
Ocean Reef Club
764 Barracuda Ln
Key Largo, FL 33037
United States
Ocean Reef Club
764 Barracuda Ln
Key Largo, FL 33037
(305) 367-3690
Planning Committee:
Daniel Martin, MD, Program Committee Chair
Neil Bressler, MD, Macula Society President
Lawrence J. Singerman, MD, Executive Secretary
 
All persons in control of content have NO relevant financial relationships to disclose except for the following persons named in the 37th Annual Scientific Program (see attached).
 

 

Available Credit

  • 18.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 18.00 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.